Erlotinib and gastrointestinal ulcer.
Kim
Young Hak
YH
Masago
Katsuhiro
K
Mishima
Michiaki
M
D000368:Aged; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D016896:Treatment Outcome
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors